{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:50:09Z","timestamp":1764402609652},"reference-count":136,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.mehy.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T17:01:14Z","timestamp":1400605274000},"page":"142-147","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A role for cAMP-driven transactivation of EGFR in cancer aggressiveness \u2013 Therapeutic implications"],"prefix":"10.1016","volume":"83","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2004.12.012","article-title":"NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways","volume":"49","author":"Schuller","year":"2005","journal-title":"Lung Cancer"},{"issue":"35","key":"10.1016\/j.mehy.2014.05.009_b0010","doi-asserted-by":"crossref","first-page":"32116","DOI":"10.1074\/jbc.M204895200","article-title":"Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases","volume":"277","author":"Kim","year":"2002","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.mehy.2014.05.009_b0015","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1074\/jbc.275.13.9572","article-title":"The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor","volume":"275","author":"Maudsley","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1163\/1568560042342329","article-title":"Src-kinase-dependent epidermal growth factor receptor transactivation in salivary mucin secretion in response to beta-adrenergic G-protein-coupled receptor activation","volume":"12","author":"Slomiany","year":"2004","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0025","first-page":"247","article-title":"Gastric mucin secretion in response to beta-adrenergic G protein-coupled receptor activation is mediated by SRC kinase-dependent epidermal growth factor receptor transactivation","volume":"56","author":"Slomiany","year":"2005","journal-title":"J Physiol Pharmacol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cellsig.2006.01.003","article-title":"Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling","volume":"18","author":"Drube","year":"2006","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/CBI20110162","article-title":"Beta2-Adrenergic receptor-induced transactivation of epidermal growth factor receptor and platelet-derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival","volume":"36","author":"Chen","year":"2012","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002","journal-title":"Nat Med"},{"issue":"37","key":"10.1016\/j.mehy.2014.05.009_b0045","doi-asserted-by":"crossref","first-page":"35451","DOI":"10.1074\/jbc.M302474200","article-title":"Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor","volume":"278","author":"Buchanan","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0050","first-page":"108","article-title":"PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system","volume":"27","author":"Ding","year":"2005","journal-title":"Exp Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0055","doi-asserted-by":"crossref","first-page":"H2111","DOI":"10.1152\/ajpheart.00838.2004","article-title":"PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42\/44 MAPK and EGFR transactivation","volume":"288","author":"Mendez","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0060","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1096\/fj.06-7581com","article-title":"EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1\/2 pathways","volume":"21","author":"Donnini","year":"2007","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jcp.21205","article-title":"Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes","volume":"214","author":"Dajani","year":"2008","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0070","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2184.2007.00459.x","article-title":"Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy","volume":"40","author":"Banu","year":"2007","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2010.03.015","article-title":"Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms","volume":"295","author":"Wu","year":"2010","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0080","doi-asserted-by":"crossref","first-page":"e40576","DOI":"10.1371\/journal.pone.0040576","article-title":"Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis","volume":"7","author":"Finetti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2014.05.009_b0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1756-9966-31-72","article-title":"Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells","volume":"31","author":"Tveteraas","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"41","key":"10.1016\/j.mehy.2014.05.009_b0090","doi-asserted-by":"crossref","first-page":"27525","DOI":"10.1074\/jbc.M803867200","article-title":"Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells","volume":"283","author":"Evaul","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0095","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1074\/jbc.M311612200","article-title":"Gs protein-coupled receptor agonists induce transactivation of the epidermal growth factor receptor in T84 cells: implications for epithelial secretory responses","volume":"279","author":"Bertelsen","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ydbio.2009.08.002","article-title":"Bovine sperm acrosome reaction induced by G-protein-coupled receptor agonists is mediated by epidermal growth factor receptor transactivation","volume":"334","author":"Etkovitz","year":"2009","journal-title":"Dev Biol"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/aja.2010.78","article-title":"Role and regulation of EGFR in actin remodeling in sperm capacitation and the acrosome reaction","volume":"13","author":"Breitbart","year":"2011","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1476-5381.2008.00087.x","article-title":"EPAC proteins transduce diverse cellular actions of cAMP","volume":"158","author":"Borland","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","article-title":"Beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1","volume":"10","author":"Zhang","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2007.09.010","article-title":"VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine","volume":"22","author":"Yang","year":"2008","journal-title":"Brain Behav Immun"},{"issue":"21","key":"10.1016\/j.mehy.2014.05.009_b0125","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1158\/0008-5472.CAN-07-0858","article-title":"Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer","volume":"67","author":"Landen","year":"2007","journal-title":"Cancer Res"},{"issue":"46","key":"10.1016\/j.mehy.2014.05.009_b0130","doi-asserted-by":"crossref","first-page":"35462","DOI":"10.1074\/jbc.M110.109579","article-title":"Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis","volume":"285","author":"Shahzad","year":"2010","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.mehy.2014.05.009_b0135","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","article-title":"Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","article-title":"Stress hormone-mediated invasion of ovarian cancer cells","volume":"12","author":"Sood","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2014.05.009_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1748-717X-5-98","article-title":"Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro","volume":"5","author":"Liao","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.mehy.2014.05.009_b0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1479-5876-11-72","article-title":"Stress hormones promote growth of B16\u2013F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism","volume":"11","author":"Valles","year":"2013","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/labinvest.2012.175","article-title":"Beta-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines","volume":"93","author":"Moretti","year":"2013","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/carcin\/bgr251","article-title":"Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention","volume":"33","author":"Schuller","year":"2012","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0165","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.4049\/jimmunol.1202364","article-title":"Catecholamine-induced beta2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression","volume":"190","author":"Shi","year":"2013","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0170","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2012.90","article-title":"Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model","volume":"92","author":"Xin","year":"2012","journal-title":"Lab Invest"},{"issue":"19","key":"10.1016\/j.mehy.2014.05.009_b0175","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","article-title":"Prostaglandin E2 regulates tumor angiogenesis in prostate cancer","volume":"68","author":"Jain","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0180","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mc.20320","article-title":"Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway","volume":"46","author":"Wang","year":"2007","journal-title":"Mol Carcinog"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.009_b0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mc.20728","article-title":"The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR\/STAT3 pathway in UVB-exposed mouse skin","volume":"50","author":"Chun","year":"2011","journal-title":"Mol Carcinog"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0190","doi-asserted-by":"crossref","first-page":"e29331","DOI":"10.1371\/journal.pone.0029331","article-title":"Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma","volume":"7","author":"Rasmuson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2014.05.009_b0195","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ncomms2413","article-title":"Src activation by beta-adrenoreceptors is a key switch for tumour metastasis","volume":"4","author":"Armaiz-Pena","year":"2013","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0200","first-page":"821","article-title":"Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications","volume":"4","author":"Ciardiello","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0205","first-page":"3233","article-title":"The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells","volume":"9","author":"Tortora","year":"1994","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0210","first-page":"23","article-title":"Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth","volume":"109","author":"Cho-Chung","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.mehy.2014.05.009_b0215","doi-asserted-by":"crossref","first-page":"D898","DOI":"10.2741\/Cho-Chung","article-title":"Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment","volume":"4","author":"Cho-Chung","year":"1999","journal-title":"Front Biosci"},{"issue":"54","key":"10.1016\/j.mehy.2014.05.009_b0220","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1038\/sj.onc.1208165","article-title":"Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion","volume":"23","author":"Neary","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.onc.1200906","article-title":"The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor","volume":"14","author":"Tortora","year":"1997","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.009_b0230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation","volume":"12","author":"Stork","year":"2002","journal-title":"Trends Cell Biol"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2014.05.009_b0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5560\/ZNC.2012.67c0222","article-title":"Cyclic adenosine monophosphate (cAMP)-induced histone hyperacetylation contributes to its antiproliferative and differentiation-inducing activities","volume":"67","author":"Yoo","year":"2012","journal-title":"Z Naturforsch C"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0240","doi-asserted-by":"crossref","first-page":"C1665","DOI":"10.1152\/ajpcell.2000.279.5.C1665","article-title":"Beta-adrenergic receptor\/cAMP-mediated signaling and apoptosis of S49 lymphoma cells","volume":"279","author":"Yan","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.mehy.2014.05.009_b0245","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V99.9.3390","article-title":"Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1\/CIP1) proteins in human acute lymphoblastic leukemia cells","volume":"99","author":"Ogawa","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.009_b0250","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/1535-7163.MCT-05-0065","article-title":"Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy","volume":"4","author":"Ali","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"10.1016\/j.mehy.2014.05.009_b0255","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1158\/0008-5472.CAN-07-0710","article-title":"Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer","volume":"67","author":"Buchanan","year":"2007","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.009_b0260","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.23100","article-title":"Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor","volume":"110","author":"Gadgeel","year":"2007","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.mehy.2014.05.009_b0265","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/cncr.25786","article-title":"Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer","volume":"117","author":"Kao","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0270","article-title":"Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 as a novel approach to enhance radiotherapy","volume":"1","author":"Fu","year":"2011","journal-title":"J Cell Sci Ther"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2014.05.009_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.04.055","article-title":"Beta2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction","volume":"665","author":"Shan","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0280","doi-asserted-by":"crossref","first-page":"e76169","DOI":"10.1371\/journal.pone.0076169","article-title":"Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0285","first-page":"1259","article-title":"A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors","volume":"6","author":"Chen","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0290","first-page":"65","article-title":"GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts","volume":"21","author":"Agrawal","year":"2002","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10637-006-2378-x","article-title":"A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers","volume":"24","author":"Goel","year":"2006","journal-title":"Invest New Drugs"},{"issue":"9754","key":"10.1016\/j.mehy.2014.05.009_b0300","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"9759","key":"10.1016\/j.mehy.2014.05.009_b0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0310","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0315","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","article-title":"COX-2 as a target for cancer chemotherapy","volume":"62","author":"Ghosh","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"32","key":"10.1016\/j.mehy.2014.05.009_b0320","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1200\/JCO.2011.35.5214","article-title":"Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study","volume":"29","author":"Groen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(12)70088-8","article-title":"Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial","volume":"13","author":"James","year":"2012","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0330","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.ejca.2011.03.035","article-title":"Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group","volume":"47","author":"Koch","year":"2011","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0335","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1093\/annonc\/mds107","volume":"23","author":"Reyners","year":"2012","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0340","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1940-6207.CAPR-11-0036","article-title":"A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer","volume":"4","author":"Sabichi","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9826","key":"10.1016\/j.mehy.2014.05.009_b0345","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2014.05.009_b0350","doi-asserted-by":"crossref","DOI":"10.1111\/bjhp.12061","article-title":"Minding the body: psychotherapy and cancer survival","author":"Spiegel","year":"2013","journal-title":"Br J Health Psychol"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2014.05.009_b0355","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000319937","article-title":"Smoking cessation: an integral part of lung cancer treatment","volume":"78","author":"Cataldo","year":"2010","journal-title":"Oncology"},{"issue":"7\u20138","key":"10.1016\/j.mehy.2014.05.009_b0360","first-page":"346","article-title":"Effect of cigarette smoking on epithelial ovarian cancer survival","volume":"55","author":"Ioffe","year":"2010","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0365","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10549-012-2276-1","article-title":"Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review","volume":"136","author":"Braithwaite","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0370","doi-asserted-by":"crossref","first-page":"e55834","DOI":"10.1371\/journal.pone.0055834","article-title":"Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0375","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2013.06.010","article-title":"Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature","volume":"65","author":"Crivelli","year":"2014","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0380","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1158\/1055-9965.EPI-13-0385","article-title":"Association of smoking history with cancer recurrence and survival in stage III-IV male gastric cancer patients","volume":"22","author":"Han","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1477-7819-11-271","article-title":"Association of body mass index and smoking on outcome of Chinese patients with colorectal cancer","volume":"11","author":"Liu","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0390","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MPA.0b013e3182a7c74b","article-title":"Smoking and body mass index and survival in pancreatic cancer patients","volume":"43","author":"Pelucchi","year":"2014","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0395","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2012.108","article-title":"Beta-Adrenergic receptor expression in vascular tumors","volume":"25","author":"Chisholm","year":"2012","journal-title":"Mod Pathol"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2014.05.009_b0400","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000337381","article-title":"Expression and functional coupling of liver beta2 - adrenoceptors in the human hepatocellular carcinoma","volume":"89","author":"Kassahun","year":"2012","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3727\/096504010X12828372551867","article-title":"Beta-adrenergic receptors in cancer: therapeutic implications","volume":"19","author":"Perez-Sayans","year":"2010","journal-title":"Oncol Res"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0410","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0714.2008.00691.x","article-title":"Expression of beta2-adrenergic receptor in oral squamous cell carcinoma","volume":"38","author":"Shang","year":"2009","journal-title":"J Oral Pathol Med"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0415","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/pros.20778","article-title":"Hormonal regulation of beta2-adrenergic receptor level in prostate cancer","volume":"68","author":"Ramberg","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.mehy.2014.05.009_b0420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000100045","article-title":"Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis","volume":"39","author":"Schuller","year":"2007","journal-title":"Prog Exp Tumor Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0425","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.24063","article-title":"Is norepinephrine an etiological factor in some types of cancer?","volume":"124","author":"Fitzgerald","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2014.05.009_b0430","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/OTT.S38403","article-title":"Beta-blockers: a novel class of antitumor agents","volume":"5","author":"Ji","year":"2012","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.mehy.2014.05.009_b0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.semcancer.2013.08.009","article-title":"Beta-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy","volume":"6 PTB","author":"Tang","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0440","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.21723","article-title":"The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB\/c nude mice is inhibited by beta-blockers","volume":"118","author":"Palm","year":"2006","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0445","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-08-2966","article-title":"Surgical stress promotes tumor growth in ovarian carcinoma","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.mehy.2014.05.009_b0450","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0455","first-page":"874","article-title":"Behavioral stress accelerates prostate cancer development in mice","volume":"123","author":"Hassan","year":"2013","journal-title":"J Clin Invest"},{"issue":"114","key":"10.1016\/j.mehy.2014.05.009_b0460","first-page":"584","article-title":"Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice","volume":"59","author":"Lin","year":"2012","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0465","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/toxsci\/kfm060","article-title":"Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation","volume":"97","author":"Wong","year":"2007","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0470","doi-asserted-by":"crossref","first-page":"e61435","DOI":"10.1371\/journal.pone.0061435","article-title":"Effect of chronic restraint stress on human colorectal carcinoma growth in mice","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.009_b0475","first-page":"4514","article-title":"Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines","volume":"9","author":"Lutgendorf","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0480","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/1535-7163.MCT-12-0809","article-title":"Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling","volume":"12","author":"Guo","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0485","doi-asserted-by":"crossref","first-page":"e29915","DOI":"10.1371\/journal.pone.0029915","article-title":"Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention","volume":"7","author":"Al-Wadei","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0490","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/1541-7786.MCR-11-0332","article-title":"Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors alpha3, alpha5, and alpha7","volume":"10","author":"Al-Wadei","year":"2012","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0495","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.taap.2008.08.012","article-title":"Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways","volume":"233","author":"Shin","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.009_b0500","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/bjc.2013.205","article-title":"Beta-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma","volume":"108","author":"Pasquier","year":"2013","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0505","doi-asserted-by":"crossref","first-page":"e60021","DOI":"10.1371\/journal.pone.0060021","article-title":"Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma","volume":"8","author":"Stiles","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0510","first-page":"334","article-title":"Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma","volume":"41","author":"Wolter","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.009_b0515","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","article-title":"Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment","volume":"2","author":"Pasquier","year":"2011","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0520","doi-asserted-by":"crossref","first-page":"466","DOI":"10.18632\/oncotarget.182","article-title":"Beta-adrenergic signaling, a novel target for cancer therapy?","volume":"1","author":"Schuller","year":"2010","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.009_b0525","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/annonc\/mdt381","article-title":"Beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort","volume":"24","author":"Hicks","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0530","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.25351","article-title":"Norepinephrine antagonists and cancer risk","volume":"128","author":"Friedman","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0535","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1185\/03007995.2013.772505","article-title":"Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials","volume":"29","author":"Monami","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0540","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.009_b0545","first-page":"11","article-title":"Beta-blockers: a new and emerging treatment for melanoma","volume":"103","author":"De","year":"2012","journal-title":"Recenti Prog Med"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0550","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.mehy.2014.05.009_b0555","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: a population- based study","volume":"29","author":"Barron","year":"2011","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.mehy.2014.05.009_b0560","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","article-title":"Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer","volume":"29","author":"Melhem-Bertrandt","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0565","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2013.09.001","article-title":"Effect of beta-Blockers and other antihypertensive drugs on the risk of melanoma recurrence and death","volume":"88","author":"De","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mehy.2014.05.009_b0570","doi-asserted-by":"crossref","unstructured":"Watkins, J et al. Improved outcomes with beta blocker use in epithelial ovarian cancer patients. Society of Gynecologic Oncology \u2013 2013 Conference , Abstract 75. 2013. Ref Type: Abstract.","DOI":"10.1016\/j.ygyno.2013.04.134"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.009_b0575","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.aje.a113213","article-title":"Heart rate: a risk factor for cancer?","volume":"114","author":"Persky","year":"1981","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0580","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/oxfordjournals.aje.a116734","article-title":"Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases","volume":"137","author":"Wannamethee","year":"1993","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0585","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0895-4356(00)00353-X","article-title":"Pulse pressure and heart rate: independent risk factors for cancer?","volume":"54","author":"Thomas","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0590","doi-asserted-by":"crossref","first-page":"e21310","DOI":"10.1371\/journal.pone.0021310","article-title":"Heart rate and risk of cancer death in healthy men","volume":"6","author":"Jouven","year":"2011","journal-title":"PLoS One"},{"issue":"10 Pt 1","key":"10.1016\/j.mehy.2014.05.009_b0595","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0895-7061(96)87747-8","article-title":"Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate","volume":"9","author":"Facchini","year":"1996","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0600","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08037059609062111","article-title":"How smoking affects blood pressure","volume":"5","author":"Omvik","year":"1996","journal-title":"Blood press"},{"issue":"9 Pt 1","key":"10.1016\/j.mehy.2014.05.009_b0605","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjhyper.2005.04.009","article-title":"Factors affecting home-measured resting heart rate in the general population: the Ohasama study","volume":"18","author":"Yamaguchi","year":"2005","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.mehy.2014.05.009_b0610","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2014.05.009_b0615","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-416673-8.00010-1","article-title":"The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer","volume":"93","author":"Ferguson","year":"2013","journal-title":"Vitam Horm"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.009_b0620","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11912-012-0265-5","article-title":"Physical activity and cancer","volume":"14","author":"Clague","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0625","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1047-2797(01)00246-0","article-title":"Hypertension, heart rate, use of antihypertensives, and incident prostate cancer","volume":"11","author":"Fitzpatrick","year":"2001","journal-title":"Ann Epidemiol"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.009_b0630","first-page":"611","article-title":"Heart rate and prostate cancer mortality: results of a prospective analysis","volume":"4","author":"Gann","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0635","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1047-2797(97)00083-5","article-title":"Blood pressure and heart rate: no evidence for a positive association with prostate cancer","volume":"7","author":"Friedman","year":"1997","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.009_b0640","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0306-4530(03)00150-1","article-title":"Urinary catecholamine levels in daily life are elevated in women at familial risk of breast cancer","volume":"29","author":"James","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.009_b0645","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.0903301","article-title":"Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor","volume":"184","author":"Glasner","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0650","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1940-6207.CAPR-11-0177","article-title":"Social stress promotes and gamma-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer","volume":"5","author":"Al-Wadei","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.009_b0655","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/fon.09.171","article-title":"Neurotransmitter receptors as central regulators of pancreatic cancer","volume":"6","author":"Schuller","year":"2010","journal-title":"Future Oncol"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0660","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/carcin\/bgp010","article-title":"Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid","volume":"30","author":"Al-Wadei","year":"2009","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.009_b0665","doi-asserted-by":"crossref","first-page":"e43376","DOI":"10.1371\/journal.pone.0043376","article-title":"Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice","volume":"7","author":"Al-Wadei","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.009_b0670","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1139\/y11-031","article-title":"GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes","volume":"89","author":"Lodewyks","year":"2011","journal-title":"Can J Physiol Pharmacol"},{"issue":"24","key":"10.1016\/j.mehy.2014.05.009_b0675","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1158\/0008-5472.CAN-05-1470","article-title":"Gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A\/extracellular signal-regulated kinase 1\/2 pathway","volume":"65","author":"Fava","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.009_b0680","first-page":"383","article-title":"The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer","volume":"19","author":"Opolski","year":"2000","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T13:10:14Z","timestamp":1565442614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0306987714002138"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.009","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for cAMP-driven transactivation of EGFR in cancer aggressiveness \u2013 Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}